Table 2 Innate immunity in the human FGT

From: Ovarian steroid hormones: effects on immune responses and Chlamydia trachomatis infections of the female genital tract

Lower genital tract (LGT) (ectocervix and vagina)

Proliferative (E2 dominant)

Secretory (P4 dominant)

References

Soluble factors (AMPs, HBD2, elafin)

↓HBD2 and elafin

↑SLPI

7, 23

Epithelial cells (multilayered, squamous)

Thick vaginal epithelium

Thinner vaginal epithelium

16

Neutrophils

(=)

(=)

53, 59

Macrophages

Vagina (=)

Vagina (=)

59

NK cells (CD45+, CD56+CD3− CD16+)

(=)

(=)

26, 31

Upper genital tract (UGT) (Endocervix and endometrium, fallopian tubes, and ovaries)

Proliferative (E2 dominant)

Secretory (P4 dominant)

References

Soluble factors (AMPs, HBDs, elafin)

↑HBD4 (endometrium) (note: HBD2 and elafin peak during menstruation) SLPI and elafin (fallopian tubes—constitutively expressed)

↑SLPI, HBD1, HBD3 (endometrium) (maximal expression)

60, 61, 62

PRRs (TLR, NOD-1, 2)

TLR10 (fallopian tubes) TLRs 1–7 but not TLR4 (endocervix)

TLRs 2, 3 5, 6, 9, including TLR4)↑(endometrium), TLR10↑(fallopian tubes)

55, 63, 64, 65, 66, 67, 68

Epithelial cells (single layer, columnar)

Thick uterine epithelium. Constitutively express IFN-É› (Type 1 IFN) in luminal and glandular cells highest in the proliferative phase

Thin uterine epithelium

16, 69

Neutrophils

(=)

Endometrial↑

54, 59, 70

Macrophages

 

Endometrial↑ (before menstruation)

31

Dendritic cells

CD83+ (=)

CD1a+↑

71

NK cells CD45+, CD56+CD3−CD16−, CD69+ CD94+

uNK ↑CTL activity

Endometrial NK cells (with NKG2D receptor) ↑MICA uNK ↓CTL activity via IL-18

10, 11, 12, 13, 14, 15, 26, 31, 40

  1. AMP, antimicrobial peptide; CD, cluster of differentiation; CTL, cytotoxic T lymphocyte; FGT, female genital tract; HBD2, human β defensin 2; IFN, interferon; IL, interleukin; SLPI, secretory leukocyte protease inhibitor; NK, natural killer; NKG2D, an activating receptor expressed on NK cells that binds to MHC class 1 chain–related protein A and B (MICA and MICB); NOD, nucleotide-binding oligomerization domain; PRR, pattern recognition receptor; TLR, Toll-like receptor;uNK, uterine natural killer.
  2. The effects of menstrual cycle phase (proliferative or secretory) on the levels (↑, increased; (=), constant; or ↓, decreased) and functions (activity) of innate immune cells, non-immune cells, and soluble factors.
PowerPoint slide